The Relationship of Diphenyleneiodonium-Induced Hypoglycaemia to the Specific Covalent Modification of NADH-Ubiquinone Oxidoreductase
The Relationship of Diphenyleneiodonium-Induced Hypoglycaemia to the Specific Covalent Modification of NADH-Ubiquinone Oxidoreductase
复制标题
DOI:
10.1042/bst0070103
复制
发表时间:
1979-02-01
影响因子:
3.9
通讯作者:
Bloxham, David P.
中科院分区:
文献类型:
--
作者:
Bloxham, David P.
The first report on the hypoglycaemic action of diphenyleneiodonium dates to observations by Stewart & Hanley (1969), who showed that it was one of the most potent hypoglycaemic compounds known. In several animal species the compound caused irreversible hypoglycaemia resulting in death at a dose of only 4mg/kg. Interestingly, the very first report on diphenyleneiodonium clearly focused on the two main features of its actions which will be developed in this article. Firstly the compound was a strong inhibitor of metabolic oxidation and secondly the inhibition showed irreversible characteristics.The inhibition of mitochondrial oxidation was subsequently pursued by Holland & Sherratt (1972), who showed that diphenyleneiodonium (5-10b~) completely inhibited ADP-linked dinitrophenol-stimulated oxidation of succinate by isolated rat liver mitochondria. This inhibition was found to be C1--dependent, since inhibition of flavin-linked substrates did not occur in CY-free media. Diphenyleneiodonium was found to catalyse a CI-/OH-exchange across the mitochondrial membrane, and this